Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trialYing–Hong Shi, Enxiao Li, Weidong Jia et al.|The Lancet. Gastroenterology & hepatology|2025Cited by 39
USP8 promotes the tumorigenesis of intrahepatic cholangiocarcinoma via stabilizing OGTGuo Long, Ledu Zhou|Cancer Cell International|2024Cited by 9